SOURCE: Xcite Energy Ltd

July 01, 2014 02:01 ET

Xcite Energy Limited Announces Exercise of Share Options

ABERDEENSHIRE, UNITED KINGDOM--(Marketwired - Jul 1, 2014) - Xcite Energy Limited (TSX VENTURE: XEL) (LSE: XEL) ("Xcite Energy" or the "Company") announces that application has been made for the admission to AIM ("Admission") of 200,000 new ordinary shares without par value in the Company ("Ordinary Shares"), pursuant to the exercise of share options, which would have otherwise expired shortly, by a former Director of the Company. The new Ordinary Shares shall rank pari passu with the Company's existing issued Ordinary Shares and dealings are expected to commence on 4 July 2014.

Following Admission, the Company's enlarged issued share capital will comprise 308,930,421 Ordinary Shares with one voting right per share. There are no shares held in treasury. The total number of voting rights in the Company is therefore 308,930,421.

This figure of 308,930,421 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This information is provided by RNS
The company news service from the London Stock Exchange

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

Contact Information

  • ENQUIRIES:

    Xcite Energy Limited
    +44 (0) 1483 549 063
    Rupert Cole / Andrew Fairclough

    Liberum (Joint Broker and Nominated Adviser)
    +44 (0) 203 100 2222
    Clayton Bush / Tim Graham

    Morgan Stanley (Joint Broker)
    +44 (0) 207 425 8000
    Andrew Foster

    Bell Pottinger
    +44 (0) 207 861 3232
    Mark Antelme / Henry Lerwill